Post-thoracotomy pain syndrome (PTPS) is a traumatic neuropathy that can affect as many as 50% of patients undergoing thoracotomy. Patients are often refractory to conservative management and may require multiple analgesics for adequate pain control. Botulinum toxin, derived from Clostridium botulinum, has many uses in treating conditions involving spasticity, dystonia, chronic migraine, and a variety of pain disorders including neuropathies. Botulinum toxin type A injections may provide an alternative or adjunct to improve symptom management in patients with PTPS.
BaumruckerSJ. Post-thoracotomy pain syndrome: an opportunity for palliative care. Am J Hosp Palliat Care. 2002;19(2):83–84.
2.
IntisoDBascianiMSantamatoAIntisoMDi RienzoF. Botulinum toxin type A for the treatment of neuropathic pain in neuro-rehabilitation. Toxins (Basel). 2015;7(7):2454–2480.
MaguireMFRavenscroftABeggsDDuffyJP. A questionnaire study investigating the prevalence of the neuropathic component of chronic pain after thoracic surgery. Eur J Cardiothorac Surg. 2006;29(5):800–805.
5.
PengZLiHZhangCQianXFengZZhuS. A retrospective study of chronic post-surgical pain following thoracic surgery: prevalence, risk factors, incidence of neuropathic component, and impact on quality of life. PLoS One. 2014;9(2):e90014.
6.
RogersMLHendersonLMahajanRPDuffyJP. Preliminary findings in the neurophysiological assessment of intercostal nerve injury during thoracotomy. Eur J Cardiothorac Surg. 2002;21(2):298–301. PubMed PMID: 11825739.
7.
AttriJPKaurRKaurHMakhniR. Post thoracotomy pain management: a review of current available modalities. North J ISA. 2016;1(1):7–10.
8.
D’amoursRHRieglerFXLittleAG. Pathogenesis and management of persistent post-thoracotomy pain. Chest Surg Clin N Am. 1998;8(3):703–722.
9.
ArgoffCE. A focused review on the use of botulinum toxin for neuropathic pain. Clin J Pain. 2002;18(suppl 6):S177–S181.
10.
BenedettiFAmanzioMCasadioC. Postoperative pain and superficial abdominal reflexes after posterolateral thoracotomy. Ann Thorac Surg. 1997;64(1):207–210.
11.
WildgaardKRavnJNikolajsenLJakobsenEJensenTSKehletH. Consequences of persistent pain after lung cancer surgery: a nationwide questionnaire study. Acta Anaesthesiol Scand. 2011;55(1):60–68.
12.
PerkinsFMKehletH. Chronic pain as an outcome of surgery: a review of predictive factors. Anesthesiology. 2000;93(4):1123–1133.
13.
KatzJJacksonMKavanaghBPSandlerAN. Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain. 1996;12(1):50–55.
14.
OchrochEAGottschalkA. Impact of acute pain and its management for thoracic surgical patients. Thorac Surg Clin. 2005;15(1):105–121.
15.
YamauchiYIsakaMAndoK. Continuous paravertebral block using a thoracoscopic catheter-insertion technique for postoperative pain after thoracotomy: a retrospective case-control study. J Cardiothorac Surg. 2017;12(1):5.
16.
GottschalkACohenSPYangSOchrochEA. Preventing and treating pain after thoracic surgery. Anesthesiology. 2006;104(3):594–600.
17.
SbruzziGSilveiraSASilvaDVCoronelCCPlentzRD. Transcutaneous electrical nerve stimulation after thoracic surgery: systematic review and meta-analysis of 11 randomized trials [in English, Portuguese]. Rev Bras Cir Cardiovasc. 2012;27(1):75–87.
18.
HuYGuanXFanL. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review. J Headache Pain. 2013;14(1):72.
19.
JeynesLGauciC. Evidence for the use of botulinum toxin in the chronic pain setting- review of the literature. Pain Pract. 2008;8(4):269–276.
20.
HowardSAudetteJRoyalM. Botulinum toxin in pain management of soft tissue syndromes. Clin J Pain. 2002;18(suppl 6):S147–S154.
21.
SimWS. Application of Botulinum toxin in pain management. Korean J Pain. 2011;24(1):1–6.
22.
RanouxDAttalNMorainFBouhassira. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol. 2008;64(3):274–284.
23.
TurkUIlhanSAlpRSurH. Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol. 2005;28(4):161–162.
24.
BohluliBMotamediMHBagheriSC. Use of Botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(1):47–50.
25.
FosterLClappLEricksonMJabbariB. Botulinum toxin A and chronic low back pain. A randomized, double-blind study. Neurology. 2001;56(10):1290–1293.
26.
VasanCWLiuWCKlussmannJPGuntinas-lichiusO. Botulinum toxin type A for the treatment of chronic neck pain after neck dissection. Head Neck. 2004;26(1):39–45.
27.
MoonYEChoiJHParkHJParkJHKimJH. Ultrasound-guided nerve block with botulinum toxin type A for intractable neuropathic pain. Toxins (Basel). 201618;8(1):pii: E18.
28.
ChenWTYuanRYChiangSC. OnabotulinumtoxinA improves tactile and mechanical pain perception in painful diabetic polyneuropathy. Clin J Pain. 2013;29(4):305–310.
